• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of rational immunosuppressive therapy in organ transplantation based on pharmacogenomic and proteomic research

Research Project

Project/Area Number 14370787
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionKeio University

Principal Investigator

TANIGAWARA Yusuke  Keio University, Department of Medicine, Professor, 医学部, 教授 (30179832)

Co-Investigator(Kenkyū-buntansha) MORITA Kunihiko  Keio University, Department of Medicine, Associate Professor, 医学部, 助教授 (80327717)
SHIMAZU Motohide  Keio University, Department of Medicine, Assistant Professor, 医学部, 講師 (70124948)
TANABE Minoru  Keio University, Department of Medicine, Assistant Professor, 医学部, 講師 (50197513)
Project Period (FY) 2002 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥13,900,000 (Direct Cost: ¥13,900,000)
Fiscal Year 2004: ¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 2003: ¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2002: ¥8,300,000 (Direct Cost: ¥8,300,000)
Keywordsimmunosuppressive agents / cardiac transplantation / liver transplantation / small bowel transplantation / biomarker / DNA microarray / protein chip / 心臓移植モデル / 小腸移植モデル / 拒絶反応バイオマーカー / シクロスポリン / 網羅的解析 / 生体肝移植 / シクロスポリンA / CYP3A / 6β-水酸化コルチゾール / コルチゾール / 拒絶反応 / CYP3A5 / TaqMan PCR法
Research Abstract

We found gene markers for predicting acute rejection and therapeutic effect of immunosuppressive agents in rat cardiac and liver transplantation. We also identified protein markers to predict acute rejection in rat small bowel transplantation.
Rat cardiac transplantation model :
Profiling of DNA expression followed by quantitative real-time PCR analysis revealed that the expression of six candidate genes (IRF1, PSMB9, TAP1, CTSS, NOS2, PIM1) in peripheral blood were significantly induced by acute rejection. The induction was reversed by cyclosporine administration. A relationship between the cyclosporine trough concentration and the gene expression could be well described by a sigmoid Emax model. The results suggested that the expression of these candidate genes were good predictors for rejection episode and therapeutic effect of immunosuppressive agents.
Rat liver transplantation model :
We found that the expression of four genes in peripheral blood were significantly increased by acute rejection in the DNA microarray analysis followed by quantitative PCR. Immunosuppressive agents reduced the expression of these candidate genes. The results suggested that the expression of these genes in peripheral blood would be a good predictor for acute rejection and therapeutic effect of immunosuppressive drugs.
Rat small bowel transplantation model :
We identified three possible biomarkers (10.1,13.0,14.8 kDa) in peripheral blood that reflected acute rejection after small bowel transplantation. Among them, lysozyme (14.8 kDa) may be useful for detecting acute rejection and for monitoring the pharmacological effects of immunosuppressants, whereas migration inhibitory factor-related protein (MRP)-8 (10.1 kDa) and MRP-14 (13.0 kDa) may be useful for detecting the early stage of allograft rejection.

Report

(4 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • 2002 Annual Research Report
  • Research Products

    (27 results)

All 2005 2004 Other

All Journal Article (13 results) Patent(Industrial Property Rights) (2 results) Publications (12 results)

  • [Journal Article] Cancer Pharmacogenomics : International Trends2005

    • Author(s)
      Yamayoshi Y, Iida E, Tanigawara Y
    • Journal Title

      Int.J.Clin.Oncol. 10・1

      Pages: 5-13

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Cancer Pharmacogenomics : International Trends2005

    • Author(s)
      Yamayoshi Y, Iida E, Tanigawara Y
    • Journal Title

      Int.J.Clin.Oncol. 10

      Pages: 5-13

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells : relevance to the release of lipids2004

    • Author(s)
      Tsutsumi T, Tanigawara Y, et al.
    • Journal Title

      Biol.Pharm.Bull. 27・1

      Pages: 24-28

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam2004

    • Author(s)
      Kosaki K, Tanigawara Y, et al.
    • Journal Title

      Brain Dev. 26・8

      Pages: 530-534

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy2004

    • Author(s)
      Takahashi Y, Tanigawara Y, et al.
    • Journal Title

      Jpn.J.Clin.Oncol. 34・6

      Pages: 342-345

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts2004

    • Author(s)
      Shimazu M, Kitajima M
    • Journal Title

      World J.Surg. 28・1

      Pages: 2-7

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Programmed death-1-programmed death-Li interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen2004

    • Author(s)
      Aramaki O, Shimazu M, et al.
    • Journal Title

      Transplantation 77・1

      Pages: 6-12

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Phorbol myristate acetate stimulates degradation of a structural analogue of platelet-activating factor to a neutral lipid in human leukemic K562 cells : relevance to the release of lipids2004

    • Author(s)
      Tsutsumi T, Tanigawara Y, et al.
    • Journal Title

      Biol.Pharm.Bull. 27

      Pages: 24-28

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam2004

    • Author(s)
      Kosaki K, Tanigawara Y, et al.
    • Journal Title

      Brain Dev. 26

      Pages: 530-534

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy2004

    • Author(s)
      Takahashi Y, Tanigawara Y, et al.
    • Journal Title

      Jpn.J.Clin.Oncol. 34

      Pages: 342-345

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts2004

    • Author(s)
      Shimazu M, Kitajima M
    • Journal Title

      World J.Surg. 28

      Pages: 2-7

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen2004

    • Author(s)
      Aramaki O, Shimazu M, et al.
    • Journal Title

      Transplantation 77

      Pages: 6-12

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen2004

    • Author(s)
      Aramaki O, Shimazu M, et al.
    • Journal Title

      Transplantation 77・1

      Pages: 6-12

    • Related Report
      2004 Annual Research Report
  • [Patent(Industrial Property Rights)] 遺伝子マーカー及びその利用2004

    • Inventor(s)
      谷川原 祐介, 他
    • Industrial Property Rights Holder
      学校法人慶應義塾
    • Industrial Property Number
      2004-165013
    • Filing Date
      2004-06-02
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 診断マーカー及び薬効マーカー、並びにそれらの利用方法2004

    • Inventor(s)
      谷川原 祐介, 他
    • Industrial Property Rights Holder
      学校法人慶應義塾
    • Industrial Property Number
      2004-368375
    • Filing Date
      2004-12-20
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Publications] S.Tatami, Y.Tanigawara, 他: "Population Pharmacokinetics of an Angiotensin II Receptor Antagonist, Telmisartan, in Healthy Volunteers and Hypertensive Patients"Drug Metabol.Pharmacokin.. 18(3). 203-211 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] N.Yamamoto, Y.Tanigawara, 他: "Phase I and Pharmacokinetic Study of KRN5500, a Spicamycin Derivative, for Patients with Advanced Solid Tumor"Japanese Journal of Clinical Oncology. 33(6). 302-308 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] E.Comets, Y.Tanigawara, 他: "Comparison of the Pharmacokinetics of S-1, an Oral Anticancer Agent, in Western and Japanese Patients"J.Pharmacokin.Pharmacodyn.. 30(4). 257-283 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] T.Tsutsumi, Y.Tanigawara, 他: "Phorbol Myristate Acetate Stimulates Degradation of a Structural Analogue of Platelet-Activating Factor to a nNutral Lipid in Human Leukemic K562 Cells : Relevance to the Release of Lipids"Biol.Pharm.Bull.. 27(1). 24-28 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 清水喜八郎, 谷川原祐介, 他: "本邦における抗MRSA薬arbekacinを中心とした使用実態"日本化学療法学会雑誌. 51(11). 717-730 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 河地茂行, 谷川原祐介, 他: "生体肝移植後のグラフトサイズがネオーラル投与後のシクロスポリン血中濃度に及ぼす影響に関する臨床研究"今日の移植. 16(6). 612-616 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Y.Tanigawara, et al.: "N-acetyltransferase2 genotype-related sulfapyridine acetylation and its adverse events"Bid Pharm. Bull. 25. 1058-1062 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] T.Kakimoto, et al.: "Thalidomide for the treatment of refractory multiple myeloma: association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome"Jpn. J Cancer Res.. 93. 1029-1036 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] T.Sakaeda, et al.: "Simvastatin and lovastatin, but not pravastatin, interact with MDR1"J Pharm. Pharmacol.. 54. 419-423 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] K.Takara, et al.: "Interaction of digoxin with antihypertensive drugs via MDR1"Life Sciences. 70. 1491-1500 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] K.Takara, et al.: "Effects of 12 Ca^<2+> antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression"Eur. J. Pharm. Sci.. 16. 159-165 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Kakumoto, et al.: "MDR1-mediated interaction of digoxm with antiarrhythmic or antianginal drugs"Bid Pharm. Bull.. 25. 1604-1607 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi